BioSyent Releases First Quarter Results-Sales Increase 70%, Profit Before Tax Up 76%
May 22, 2013 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - May 22, 2013) - BioSyent Inc. (TSX VENTURE:RX) ("BioSyent") released today a summary of its First Quarter (Q1) 2013 financial results.
...
Confirmation of BioSyent Inc. 2013 AGM Location
May 17, 2013 16:01 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - May 17, 2013) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today announced that certain documents (the Proxy and the VIF) that have been mailed to...
BioSyent Releases Full Year 2012 Results-Sales Increase 79%, Net Income Up 267%; 3 Year CAGR 70%; Q4 Sales Increase 89%
March 21, 2013 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwire - March 21, 2013) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) released today a summary of its Fiscal 2012 and Fourth Quarter (Q4) 2012 financial results....
BioSyent Named to the 2013 TSX Venture Top 50(R) Ranking-2nd Consecutive Year Chosen as a Top TSX Performer
February 14, 2013 08:00 ET
|
BioSyent Inc.;TSX Venture Top 50
TORONTO, ONTARIO--(Marketwire - Feb. 14, 2013) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) announced today that it has been named as one of the TSX Venture Top 50 companies.
...
BioSyent Presents at MicroCapClub Invitational
February 12, 2013 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwire - Feb. 12, 2013) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) announced today that it has been selected to present at the first ever MicroCapClub...
BioSyent Announces Issue Of Stock Options
December 18, 2012 17:59 ET
|
BioSyent Inc.
MISSISSAUGA, ONTARIO--(Marketwire - Dec. 18, 2012) - BioSyent Inc. ("BioSyent", the "Company") (TSX VENTURE:RX) announces the grant of 40,000 stock options to certain Officers, Employees...
BioSyent Releases Third Quarter Results; Record Quarterly Sales and Profit: Sales Up 60%, Profit Up 79%
November 15, 2012 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwire - Nov. 15, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Third Quarter (Q3) 2012 financial results.
...
BioSyent Releases Second Quarter Results; Record Quarterly Sales and Profit: Sales Up 89%, Profit Up 196%
August 22, 2012 17:21 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwire - Aug. 22, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Second Quarter (Q2) 2012 financial results.
...
BioSyent Pharma Signs Exclusive Licensing and Distribution Agreement For Two New Drug Products
August 16, 2012 17:33 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwire - Aug. 16, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has signed an exclusive...
BioSyent Announces: Health Canada Approves New FeraMAX(R) Powder-Water Soluble Polysaccharide-Iron Complex
July 25, 2012 16:21 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwire - July 25, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today announced that its subsidiary BioSyent Pharma Inc. has received marketing approval from...